The roX genes of Drosophila produce a transcript that is spliced and polyadenylated but not translated. Recent work has shown that these genes provide an element that the dosage compensation complex of Drosophila uses to initiate its association with the X chromosome.
In mammals, dosage compensation -the equalization of the levels of X-linked gene products between females, which have two X chromosomes, and males, which have a single X -is achieved by inactivating one of the two X chromosomes, early during development, in the somatic cells of females. The situation in Drosophila is quite different, in that both X chromosomes are active, simultaneously, in the somatic cells of females. In this group of organisms, dosage compensation is achieved by a regulatory mechanism that doubles the rate of transcription of most X-linked genes in males. Recent studies have provided intriguing new insights into the mechanism by which gene expression from one entire, specific chromosome is globally up-regulated.
Over the years, genetic screens and phenotypic-product assays have led to the identification of five positive regulators of dosage compensation in Drosophila (reviewed in [1] ). These regulators, collectively referred to as male-specific lethal (MSL) proteins, form a multi-subunit complex that associates at numerous sites exclusively along the X chromosome in males. As a consequence of this association, a particular isoform of histone H4, acetylated at lysine 16, is preferentially found along this chromosome (reviewed in [2] ). In females, the MSL complex fails to assemble because the transcript encoding one of its components, MSL2, is not translated. Ectopic expression in females of an msl-2 cDNA lacking the translational repression sites leads to the formation of the MSL complex and to a concomitant loss of viability that results, presumably, from the hypertranscription of both X chromosomes [3, 4] .
How the MSL complex targets the X chromosome and becomes associated with its sites of action on X chromatin in males or in transgenic females has long been a mystery. An important clue was recently provided by Kelley et al. [5] , who succeeded in inducing the ectopic association and spreading of the MSL complex by transducing either one of the two known 'RNA on the X' (roX) genes to autosomal sites. These two X-linked genes normally produce nontranslated transcripts in both sexes, but their accumulation depends on the integrity of the MSL complex. The roX transcripts are therefore found only in males or in transgenic females that have been induced to form an MSL complex [6, 7] . In these individuals, the roX RNAs associate with the X chromosome [6, 7] with a distribution that mirrors that of the MSL complex [8] . As the simultaneous deletion of the roX1 and roX2 genes results in the absence of any visible complex in male embryos [8] , these two RNAs must be the major, if not the only, RNAs associated with complex formation.
By exploiting the polytene chromosomes of Drosophila salivary gland cells, and using indirect immunofluorescence microscopy, Kelley et al. [5] observed that the MSL proteins bound to roX1 or roX2 transgenes located on an autosome. Remarkably, some nuclei were seen to exhibit multiple fluorescent bands on either side of the roX1 gene, indicating that the MSL complex had spread from the transgene locus to autosomal regions where it is not found normally. In heterozygous larvae, where just one of the two homologous autosomes carries a roX1 transgene, spreading was found to occur in trans along the paired homologue, although to a less extent than on the roXbearing chromosome. Both roX1 and roX2 RNAs were present in the adventitious bands surrounding the roX1 transgene, consistent with the observation that these RNAs are not limited to the vicinity of the locus from which they are transcribed.
Insights into the targeting of the MSL complex to the X chromosome have been gained through studies with incomplete or inactive forms of the complex. When any one of the MSL proteins -MSL3, MLE or MOF -was missing, or the ATP-dependent RNA helicase activity of MLE or the histone acetyl transferase activity of MOF was abolished by mutation, the remaining MSL1 and MSL2 subunits were seen to bind to a small subset of complexbinding sites along the X chromosome (reviewed in [9] ). These 30-40 sites, identified by indirect immunofluorescence detection of MSL1 or MSL2 antisera on polytene chromosomes, are thought to represent points of entry or assembly for the MSL complex [10] . Interestingly, cytological mapping showed that the roX1 and roX2 genes themselves reside within two of these sites.
On the basis of these observations and their recent findings with roX transgenes, Kelley et al. [5] propose the following model (Figure 1 ). The MSL proteins enter the X chromosome at specific entry sites and, at least at the two of those sites where the roX genes are located, they form complexes that incorporate roX RNA. These mature complexes can then associate with any of the other entry sites, from where they spread into neighboring regions along the chromosome. Movement of complexes between entry sites would explain the fact that roX1 and roX2 RNAs are found at the same sites. Do the roX RNAs play a role in attracting the complex to the X chromosome, or are they simply an integral subunit of the complex that must be available during its assembly? Binding of the MSL complex to a partially deleted and inactive roX1 transgene [5] would suggest that it recognizes some feature of the sequence in the RNA or, in the case of a truncated transgene that is not transcribed, in the DNA antisense strand, and would argue in favor of the first alternative. The ability of the MSL complex to access all of the entry sites, whether they contain a roX gene or not, would argue in favor of the second alternative.
Binding to a truncated roX1 transgene that is not transcribed may not reflect the recognition by the MSL complex of the RNA-encoding DNA sequence, but rather may be the result of an effect of roX DNA on the local chromatin configuration, creating an entry site analogous to the one where the roX gene is normally located. Some characteristic inherent to the roX genes and to a few other sequences present along the X chromosome may, for example, cause a sequence-directed positioning of nucleosomes that enables the MSL complex to enter chromatin. From these sites, the complex may spread by the epigenetic modification of neighboring nucleosomes. Irrespective of these considerations, the new results show that, rather than binding at once all along the X chromosome, the MSL complex initially gains access at a limited number of entry points, from where it then spreads to all of its sites of action. 
